Senate Republicans are plotting deeper Medicaid cuts to bankroll tax reforms, ditching previous plans to trim Medicare ...

Supernus Pharmaceuticals said it is acquiring Sage Therapeutics, the distressed maker of a drug for postpartum depression, ...

Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Eli Lilly and Company ( NYSE: LLY) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 8:00 AM ET Lucas E. Montarce - Executive VP & CFO Michael Czapar - Director of Investor ...

Diabetes care startup Omada Health went public Friday 14 years after its founding. Here's what its major investors' stakes ...

The 71st Fortune 500 ranks America’s largest companies by 2024 fiscal year revenue. Key healthcare takeaways from the most recent listing from Fortune, released June 2: 1. The list includes 12 ...

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was associated with significantly improved overall survival in a phase 3 trial for ...

We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the bulls’ thesis on CI. The Cigna Group (CI)'s share was trading at $312.68 as ...

Still, Subramanian highlighted six healthcare stocks that could be worth a look: drug distributor Cardinal Health, CVS Health, Eli Lilly, health insurer Cigna Group, Danaher, and Thermo Fisher ...

Evernorth — the Cigna division that oversees the Express ... lowers blood sugar levels and makes people less hungry. Eli Lilly's Zepbound contains tirzepatide, a drug that controls blood sugar ...